Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
2.
J Dent Res ; 93(12): 1187-95, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25139365

ABSTRACT

Conditions such as congenital anomalies, cancers, and trauma can all result in devastating deficits of bone in the craniofacial skeleton. This can lead to significant alteration in function and appearance that may have significant implications for patients. In addition, large bone defects in this area can pose serious clinical dilemmas, which prove difficult to remedy, even with current gold standard surgical treatments. The craniofacial skeleton is complex and serves important functional demands. The necessity to develop new approaches for craniofacial reconstruction arises from the fact that traditional therapeutic modalities, such as autologous bone grafting, present myriad limitations and carry with them the potential for significant complications. While the optimal bone construct for tissue regeneration remains to be elucidated, much progress has been made in the past decade. Advances in tissue engineering have led to innovative scaffold design, complemented by progress in the understanding of stem cell-based therapy and growth factor enhancement of the healing cascade. This review focuses on the role of biomaterials for craniofacial bone engineering, highlighting key advances in scaffold design and development.


Subject(s)
Biocompatible Materials/therapeutic use , Plastic Surgery Procedures/methods , Skull/surgery , Tissue Engineering/methods , Tissue Scaffolds , Facial Bones/surgery , Humans , Intercellular Signaling Peptides and Proteins/therapeutic use , Prosthesis Design , Stem Cell Transplantation/methods
3.
Child Care Health Dev ; 40(5): 698-705, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24438547

ABSTRACT

BACKGROUND: Attention-deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders of childhood and can be associated with obesity. The aim of this study was to reveal the connection between ADHD symptoms, food habits and obesity. METHODS: We examined 12 350 children (6010 boys, 6340 girls) from 27 elementary schools in Cheonan, the Republic of Korea. The study subjects were 5- to 13-year-old children (9.4 ± 1.7 years). Parents completed the DuPaul ADHD Rating Scale. Food habits were measured by a questionnaire adapted from the Korea Youth Risk Behavior Web-based Survey and a validated mini-dietary assessment tool. The full set of hypothesized associations was tested using covariance structural modelling. RESULTS: The prevalence of ADHD was 7.6% and that of obesity was 4.5% in our study population. The data was well fit by the model. ADHD was associated with body mass index (BMI; standardized ß = 0.086, P < 0.001). Bulimic dietary behaviours was related to BMI (standardized ß = 0.548, P < 0.001). Socio-economic status was associated with BMI (standardized ß = -0.017, P = 0.027). CONCLUSION: Our analysis suggested that ADHD was a risk factor for obesity through dietary behavioural change and socio-economic status.


Subject(s)
Attention Deficit Disorder with Hyperactivity/complications , Attention Deficit Disorder with Hyperactivity/epidemiology , Feeding Behavior/psychology , Obesity/complications , Obesity/epidemiology , Adolescent , Attention Deficit Disorder with Hyperactivity/psychology , Body Mass Index , Child , Comorbidity , Cross-Sectional Studies , Female , Health Behavior , Humans , Male , Obesity/psychology , Risk Factors , Social Class
5.
Nephron Exp Nephrol ; 115(1): e1-8, 2010.
Article in English | MEDLINE | ID: mdl-20185935

ABSTRACT

AIMS: Idiopathic nephrotic syndrome is known as a disease of the renal glomerular epithelial cells (podocytes). Recent advances in podocyte biology showed that podocytopathy is the culprit of nephrotic syndrome. To obtain comprehensive information about the response of podocytes to injury, we investigated the gene expression profile of podocytes in response to puromycin aminonucleoside (PAN)-induced injury. METHODS: Differentiated mouse podocyte cell line (MPC5) cells were treated with 25 microg/ml PAN for 24, 48, or 72 h. Gene expression profiles of these cells were analyzed. Real time PCR analysis was used to confirm the findings of microarray. RESULTS: Expression levels of 23 genes (differentially expressed genes, DEGs), including laminin alpha(1) and MMP3, were significantly different between PAN-treated podocytes and untreated cells. Gene ontology of DEGs indicated that their functional categories were cell adhesion, extracellular matrix (ECM) formation, and ECM degradation. Real-time PCR and indirect immunohistochemistry of PAN-treated and untreated podocytes confirmed the differential expression of DEGs. CONCLUSION: Using unbiased global gene expression profiling, we found that podocytes respond to PAN-induced injury by down-regulating the expression of genes involved in cell adhesion and extracellular matrix.


Subject(s)
Podocytes/metabolism , Puromycin Aminonucleoside/administration & dosage , Transcriptional Activation/physiology , Animals , Cell Line , Dose-Response Relationship, Drug , Gene Expression Profiling , Mice , Podocytes/drug effects , Transcriptional Activation/drug effects
6.
Eur J Surg Oncol ; 35(7): 728-33, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19188040

ABSTRACT

AIM: Sporadic pancreatic endocrine tumors (PET) can be managed surgically with excellent outcomes. The aim of this study was to analyze surgical outcomes and factors influencing survival. METHODS: Between 1995 and 2007, 96 patients with sporadic PET who underwent surgery at our institution were retrospectively reviewed for clinicopathologic variables and outcomes according to the World Health Organization (WHO) classifications. RESULTS: Thirty-nine patients had well-differentiated tumors (WDT) with benign behavior, 23 had uncertain behavior, 27 had low-grade carcinoma, and 7 were diagnosed with high-grade carcinoma. R0 resection was performed in 84 patients. No recurrence was observed in WDT regardless of its behavior or curability but 16 of 34 patients with carcinoma had recurrence. Five-year overall survival (OS) for R0-resected patients with carcinoma was 57%, and OS at 3 years for R1/R2-resected patients was 23% (P = 0.012). The WHO classification and R0 resection were independent prognostic factors in multivariate analysis. CONCLUSIONS: This single institutional experience demonstrated that surgical resection is curative for WDT and recurrences are frequent in spite of curative resection for malignant PET. The WHO classification and R0 resection remained independent prognostic factor.


Subject(s)
Endocrine Gland Neoplasms/surgery , Neuroendocrine Tumors/surgery , Pancreatic Neoplasms/surgery , Adolescent , Adult , Aged , Endocrine Gland Neoplasms/mortality , Female , Humans , Male , Middle Aged , Neuroendocrine Tumors/mortality , Pancreatic Neoplasms/mortality , Survival Analysis , Treatment Outcome , Young Adult
8.
Neuroscience ; 128(1): 169-76, 2004.
Article in English | MEDLINE | ID: mdl-15450364

ABSTRACT

We hypothesized that glutamate (Glu) released from the peripheral terminals of primary afferents contributes to the generation of mechanical hyperalgesia following peripheral nerve injury. Nerve injury was performed on rats with a lumbar 5 spinal nerve lesion (L5 SNL), which was preceded by L5 dorsal rhizotomy (L5 DR) to avoid the potential central effects induced by L5 SNL through the L5 dorsal root. Mechanical hyperalgesia, as evidenced by a reduction in paw withdrawal threshold (PWT), was short-lasting (<6 days) after L5 DR, but persistent (>42 days) after L5 SNL preceded by L5 DR. When an intraplantar injection into the affected hind paw was given immediately before L5 SNL, non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 (20 nmol), group-I metabotropic Glu (mGlu) receptor antagonist DL-amino-3-phosphonopropionic acid (DL-AP3; 70 nmol), and selective group-II mGlu receptor agonist 4-aminopyrrolidine-2,4-dicarboxylate (APDC; 20 nmol) delayed the onset of PWT reduction for 1-4 days. However, this onset was not affected by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid/kainate receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4,-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 100 nmol). When the same injection was given after L5 SNL-induced mechanical hyperalgesia had been established, MK-801 reversed the PWT reduction for 30-75 min, whereas NBQX, DL-AP3, or APDC had no effect. These results suggest that the manipulation of the peripheral Glu receptors reduces neuropathic pain, by blocking NMDA and group-I mGlu receptors and by stimulating group-II mGlu receptor during the induction phase of neuropathic pain, but only by blocking the NMDA receptor during its maintenance phase.


Subject(s)
Hyperalgesia/physiopathology , Neuralgia/metabolism , Receptors, Glutamate/metabolism , Animals , Disease Models, Animal , Excitatory Amino Acid Antagonists/pharmacology , Hyperalgesia/metabolism , Male , Pain Measurement , Pain Threshold/physiology , Rats , Rats, Sprague-Dawley , Receptors, Glutamate/drug effects , Rhizotomy , Spinal Nerves/injuries , Spinal Nerves/physiopathology
10.
Clin Anat ; 14(5): 324-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11754220

ABSTRACT

The osteological and morphological variations of the prominences in the bony palate of 160 Korean skulls were studied. The frequency of the occurrence of the posterior palatine crest, located on the posterior border of the greater palatine foramen, was 13.8%. Palatal ridges were observed commonly in the skulls; however, the smooth type, which has no palatal ridges in the palate, was shown in 14.7% of cases, and palatal spines were observed in 33.8%. The prevalence of palatal tubercles was 11.6%, and all were found in the molar region. The palatine torus was found in 18.8% of cases and the most common type was along the median palatine suture from the incisive foramen to the posterior border of the palatine bone (63.3%). No significant differences between sexes or sides were found in the posterior palatine crest, palatal ridges, and palatal tubercle. However, the sex distribution of the palatine torus was significantly different (P < 0.05). These results would be helpful clinically in fabricating maxillary complete dentures for edentulous patients.


Subject(s)
Palate, Hard/anatomy & histology , Adult , Aged , Denture, Complete , Ethnicity , Humans , Korea , Middle Aged , Sex Factors
11.
J Clin Pathol ; 54(9): 703-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11533078

ABSTRACT

AIMS: To assess the importance of tumour necrosis factor alpha (TNF-alpha) promoter polymorphism in relation to infection with the cytotoxin associated gene A (cagA) subtype of Helicobacter pylori within a dyspeptic Korean population. METHODS: Eighty three patients with gastric disease and 113 healthy controls were studied. The DNA from gastric biopsy specimens was analysed by H pylori specific and cagA specific polymerase chain reaction (PCR). To characterise TNF-alpha polymorphism at positions -308 and -238, PCR based restriction fragment length polymorphism analysis was performed. RESULTS: Helicobacter pylori infection was closely correlated with G to A transition at position -308 of the TNF-alpha promoter when compared with healthy controls (odds ratio (OR), 2.912; 95% confidence interval (CI), 1.082 to 7.836; p = 0.034). Although TNF-alpha -308 polymorphism in patients with H pylori was not significantly different from that in patients without H pylori, the -308A polymorphism was strongly associated with H pylori cagA subtype infection when compared with the polymorphism in cagA negative H pylori infection (OR, 8.757; 95% CI, 1.413 to 54.262; p = 0.019) and healthy controls (OR, 3.683; 95% CI, 1.343 to 10.101; p = 0.011). G to A genetic change at position -238 of the TNF-alpha gene was not significantly associated with H pylori cagA subtype infection. In addition, genetic polymorphisms at both sites of the TNF-alpha promoter in patients with H pylori infection did not correlate with the severity of disease. CONCLUSION: TNF-alpha -308A polymorphism was significantly related to infection with the H pylori cagA subtype in Korean patients with gastric disease.


Subject(s)
Antigens, Bacterial , Bacterial Proteins/genetics , Helicobacter Infections/genetics , Helicobacter pylori/genetics , Polymorphism, Genetic , Stomach Diseases/genetics , Tumor Necrosis Factor-alpha/genetics , Bacterial Typing Techniques , Genetic Predisposition to Disease , Genotype , Helicobacter Infections/complications , Helicobacter Infections/microbiology , Helicobacter pylori/classification , Humans , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic , Stomach Diseases/microbiology , Stomach Neoplasms/genetics , Stomach Neoplasms/microbiology
12.
Toxicol Lett ; 122(1): 21-31, 2001 May 31.
Article in English | MEDLINE | ID: mdl-11397554

ABSTRACT

Here we report that lymphocyte functions were down-regulated by cyanobacterial hepatotoxin microcystin. Treatment of three microcystin (MC) isotypes, MC-LR, MC-YR and nodularin, on B6C3F1 mouse splenocytes produced dose-dependent inhibition of in vitro polyclonal antibody response and lymphoproliferation to LPS. ConA-induced lymphoproliferative response was decreased by MC-YR and nodularin, but no significant effect was observed in the MC-LR treatment. Intraperitoneal administration of nodularin into B6C3F1 mice decreased humoral immune responses to sheep red blood cell (sRBC), and the inhibitory effect became severe when hepatic uptake of nodularin was blocked by rifampicin. Each MC 1 microM suppressed phorbol 12-myristate 13-acetate (PMA) plus ionomycin-induced IL-2 mRNA expression in splenocytes and thymocytes, but not in EL-4 mouse thymoma cells. To further characterize the mechanism for the reduced IL-2 mRNA level, IL-2 mRNA stability was measured using RT-PCR. Deprivation of PMA/ionomycin stimuli from activated splenocytes and blockade of new transcription resulted in destabilization of IL-2 mRNA, which was accelerated by MC treatment. These results demonstrated that MC down-regulated lymphocyte functions and the immunosuppression was mediated, at least in part, through decreased IL-2 mRNA stability.


Subject(s)
Interleukin-2/genetics , Peptides, Cyclic/pharmacology , RNA Stability/drug effects , RNA, Messenger/drug effects , T-Lymphocytes/drug effects , Animals , Antibody Formation/drug effects , Bacterial Toxins/chemistry , Bacterial Toxins/pharmacology , Cell Division/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Down-Regulation , Female , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Microcystins , RNA, Messenger/genetics , RNA, Messenger/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Tumor Cells, Cultured
13.
Cancer Lett ; 166(1): 41-6, 2001 May 10.
Article in English | MEDLINE | ID: mdl-11295285

ABSTRACT

We investigated the potential association of tumor necrosis factor-alpha (TNF-alpha) promoter polymorphisms with cancers. The study included 169 patients with gastric cancer, uterine cervical cancer, colorectal cancer, or renal cell carcinoma and 92 healthy controls. The -308 and -238 polymorphisms in the TNF-alpha promoter were analyzed by PCR-restriction fragment length polymorphism (RFLP). The proportion of individuals carrying the TNF-238A allele was significantly lower in the cancer group than in the control group. The odds ratio for cancer in subjects with the TNF-238A allele was 0.25 (95% CI, 0.10-0.64). No association was found between the -308 polymorphism and cancers. These results suggest that the -238A allele has a protective function against cancers.


Subject(s)
Genetic Predisposition to Disease , Neoplasms/genetics , Polymorphism, Genetic , Tumor Necrosis Factor-alpha/genetics , Gene Frequency , Genotype , Humans , Polymorphism, Restriction Fragment Length , Polymorphism, Single Nucleotide , Promoter Regions, Genetic
14.
J Oral Rehabil ; 28(2): 125-32, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11298260

ABSTRACT

The placement of dental implants in the molar region of the maxilla is often difficult because of insufficient bone volume and the inferior bone quality. In order to avoid these limitations, the pillar of bone, which is composed of the maxillary tuberosity, the pyramidal process of the palatine bone and the pterygoid process of the sphenoid bone, was introduced for implant placement. In fact, the pyramidal process is the posterior structure where implants are placed but until now, there is no available data of the size or shape of the pyramidal process. Therefore, we measured the height, anteroposterior distance and mediolateral distance of the pyramidal process and observed the shape of lateral and posterior surfaces of the pyramidal process of 54 Korean edentulous dry skulls in this study. The height was 13.1 mm (male: 13.6 mm, female: 12.4 mm). The anteroposterior distance was 6.5 mm (male: 6.7 mm, female: 6.1 mm). The mediolateral distance was 9.5 mm (male: 9.9 mm, female: 9.0 mm). The most common type was the right-angled triangle in the lateral surface (44.4%) and in the posterior surface (66.7%). There was no statistical significance between the male and the female in all items (P > 0.05). These results provide anatomical features in relation to placement of dental implants in the molar region of the maxilla and would be useful in treatment planning of partially or completely edentulous patients.


Subject(s)
Dental Implantation, Endosseous , Dental Implants , Maxilla/anatomy & histology , Palate, Hard/anatomy & histology , Sphenoid Bone/anatomy & histology , Aged , Aged, 80 and over , Cephalometry , Chi-Square Distribution , Dental Arch/anatomy & histology , Female , Humans , Jaw, Edentulous/pathology , Male , Middle Aged , Molar , Patient Care Planning , Sex Factors , Statistics as Topic
15.
Neurosci Lett ; 301(1): 17-20, 2001 Mar 23.
Article in English | MEDLINE | ID: mdl-11239706

ABSTRACT

The effects of transcutaneous electrical stimulation and systemic injection of phentolamine, a non-specific alpha-adrenergic antagonist, on the behavioral signs of mechanical allodynia and cold hyperalgesia in rats with nerve injury were investigated. Mechanical allodynia and cold hyperalgesia were evaluated by measuring the paw withdrawal frequency (PWF) resulting from repetitive application of a von Frey hair and the paw lift duration (PLD) at a cold temperature, respectively. After a unilateral nerve injury, both PWF and PLD increased in the injured hind paw. Application of low-frequency, high-intensity transcutaneous electrical stimulation (LFHI-TES) to the injured hind paw depressed the injury-induced increased PWF, whereas it had no effect on the injury-induced increased PLD. Naloxone reversed the LFHI-TES produced depression of PWF. Intraperitoneal administration of phentolamine depressed the injury-induced increased PLD without affecting the injury-induced increased PWF. Our results suggest that LFHI-TES, which activates the endogenous opioid systems, produces an antinociceptive effect that appears to be related to whether or not the pain is mediated by sympathetic activity.


Subject(s)
Adrenergic alpha-Antagonists/pharmacology , Hyperalgesia/therapy , Pain Measurement/drug effects , Peripheral Nervous System Diseases/therapy , Phentolamine/pharmacology , Transcutaneous Electric Nerve Stimulation , Animals , Cold Temperature , Hindlimb/drug effects , Male , Pain Measurement/methods , Rats , Rats, Sprague-Dawley , Spinal Nerves/injuries , Touch
16.
Cancer Lett ; 163(1): 83-93, 2001 Feb 10.
Article in English | MEDLINE | ID: mdl-11163111

ABSTRACT

We have compared the anti-proliferative effects of ursodeoxycholic acid (UDCA), chenodeoxycholic acid (CDCA) and their derivatives, HS-1183, HS-1199 and HS-1200, on MCF-7 (wild-type p53) and MDA-MB-231 (mutant p53) cells. While UDCA and CDCA exhibited no significant effect, their novel derivatives inhibited the proliferation of both cell lines in a concentration-dependent manner, concomitant with apoptotic nuclear changes and the increase of a sub-G1 population and DNA fragmentation. Furthermore, we also observed an increase in the ratio of pro-apoptotic protein Bax to anti-apoptotic protein Bcl-2 and cleavages of lamin B and poly(ADP-ribose) polymerase (PARP) in MCF-7 and MDA-MB-231 cells. Cell cycle related proteins, cyclin D1 and D3, as well as retinoblastoma protein (pRb) were down-regulated, while the level of cyclin-dependent kinase inhibitor p21(WAF1/CIP1) was increased in both cancer cells after treatment with novel bile acids. These findings suggest that these cytotoxic effects of novel bile acid derivatives on human breast carcinoma cells were mediated via apoptosis through a p53-independent pathway.


Subject(s)
Apoptosis/drug effects , Breast Neoplasms/prevention & control , Chenodeoxycholic Acid/pharmacology , Tumor Suppressor Protein p53/physiology , Ursodeoxycholic Acid/pharmacology , Blotting, Western , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Survival/drug effects , Cyclin D1/drug effects , Cyclin D1/metabolism , Cyclin D3 , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/drug effects , Cyclins/metabolism , DNA Fragmentation/drug effects , DNA, Neoplasm/drug effects , DNA, Neoplasm/genetics , DNA, Neoplasm/metabolism , Dose-Response Relationship, Drug , Humans , Phosphorylation/drug effects , Retinoblastoma Protein/drug effects , Retinoblastoma Protein/metabolism , Tumor Cells, Cultured , Tumor Suppressor Protein p53/drug effects , Tumor Suppressor Protein p53/metabolism
17.
Mol Cells ; 10(3): 241-6, 2000 Jun 30.
Article in English | MEDLINE | ID: mdl-10901160

ABSTRACT

Methylchlorogenic acid (MC) is one of the main components in the leaves of Eriobotrya japonica. We previously reported that MC is the most potent antioxidant among several components of Eriobotrya japonica, and its antioxidant activity is stronger than that of chlorogenic acid. Antioxidants are expected to inhibit redox-sensitive NFkappaB activation since NFkappaB is readily influenced by cellular oxidative state. Based on these findings, in vivo experiments with MC were conducted to determine its ability to downregulate the NFkappaB activation in mouse liver. Results clearly showed that MC is a potent suppressor of BHP-induced NFkappaB activation. We observed a significant reduction by MC on BHP-induced translocation of p65 subunit of NFkappaB. This may be due to formation of p50/p65 heterodimer, which is mainly inducible NFkappaB. MC slightly blocked the BHP-induced IkappaB alpha degradation. There is a possibility of IkappaB alpha resynthesis via activated NFkappaB during a 5 h waiting period following BHP injection. The present results suggest that MC may inhibit NFkappaB activation, exhibiting its ability to downregulate the NFkappaB-dependent gene expression. Thus, it can be expected that MC may have potential for therapeutic intervention on various NFkappaB-dependent pathological conditions such as inflammatory or possibly mutagenic processes.


Subject(s)
Antioxidants/pharmacology , Chlorogenic Acid/pharmacology , NF-kappa B/metabolism , Rosales/chemistry , tert-Butylhydroperoxide/pharmacology , Active Transport, Cell Nucleus/drug effects , Animals , Antioxidants/isolation & purification , Blotting, Western , Cell Nucleus/chemistry , Cell Nucleus/metabolism , Chlorogenic Acid/analogs & derivatives , Chlorogenic Acid/isolation & purification , Electrophoresis, Polyacrylamide Gel , Gene Expression Regulation , I-kappa B Proteins/metabolism , Liver/chemistry , Male , Mice , Mice, Inbred ICR , NF-kappa B/antagonists & inhibitors , NF-kappa B/chemistry , Protein Transport , Random Allocation
18.
Yonsei Med J ; 41(2): 252-7, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10817027

ABSTRACT

We investigated the adrenergic sensitivity of afferent fibers in the L4 dorsal roots of rats with a unilateral ligation of the L5-L6 spinal nerves. About 12% of nociceptive fibers on the affected side were excited by sympathetic stimulation or by intra-arterial injection of norepinephrine which did not affect A beta-fiber activity. Sympathetic excitation of nociceptive fibers was suppressed by alpha 1-antagonist prazosin, while it was unaffected by alpha 2-antagonist yohimbine. Most of these fibers were excited by intra-arterial injection of alpha 1-agonist phenylephrine, without being affected by an injection of alpha 2-agonist clonidine. Sympathetic excitation was blocked by lidocaine applied near the receptive fields of recorded fibers. The results suggested that some nociceptors remaining intact after partial nerve injury become sensitive to sympathetic activity by the mediation of alpha 1-adrenoceptors in the peripheral endings.


Subject(s)
Nerve Fibers/physiology , Nociceptors/physiology , Pain/physiopathology , Receptors, Adrenergic, alpha-1/physiology , Animals , Male , Norepinephrine/pharmacology , Rats , Rats, Sprague-Dawley
19.
Yonsei Med J ; 40(4): 331-8, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10487135

ABSTRACT

Experiments were designed to characterize the cellular mechanisms of action of endothelium-derived vasodilator substances in the rabbit femoral artery. Acetylcholine (ACh, 10(-8)-10(-5) M) induced a concentration-dependent relaxation of isolated endothelium-intact arterial rings precontracted with norepinephrine (NE, 10(-6) M). The ACh-induced response was abolished by the removal of endothelium. NG-nitro-L-arginine (L-NAME, 10(-4) M), an inhibitor of NO synthase, partially inhibited ACh-induced endothelium-dependent relaxation, whereas indomethacin (10(-5) M) showed no effect on ACh-induced relaxation. 25 mM KCl partially inhibited ACh-induced relaxation by shifting the concentration-response curve and abolished the response when combined with L-NAME and NE. In the presence of L-NAME, ACh-induced relaxation was unaffected by glibenclamide (10(-5) M) but significantly reduced by apamin (10(-6) M), and almost completely blocked by tetraethylammonium (TEA, 10(-3) M), iberiotoxin (10(-7) M) and 4-aminopyridine (4-AP, 5 x 10(-3) M). The cytochrome P450 inhibitors, 7-ethoxyresorufin (7-ER, 10(-5) M) and miconazole (10(-5) M) also significantly inhibited ACh-induced relaxation. Ouabain (10(-6) M), an inhibitor of Na+, K(+)-ATPase, or K(+)-free solution, also significantly inhibited ACh-induced relaxation. ACh-induced relaxation was not significantly inhibited by 18-alpha-glycyrrhetinic acid (18 alpha-GA, 10(-4) M). These results of this study indicate that ACh-induced endothelium-dependent relaxation of the rabbit femoral artery occurs via a mechanism that involves activation of Na+, K(+)-ATPase and/or activation of both the voltage-gated K+ channel (Kv) and the large-conductance, Ca(2+)-activated K+ channel (BKCa). The results further suggest that EDHF released by ACh may be a cytochrome P450 product.


Subject(s)
Biological Factors/physiology , Femoral Artery/physiology , Potassium Channels/physiology , Acetylcholine/pharmacology , Animals , Female , Femoral Artery/drug effects , In Vitro Techniques , Male , Rabbits , Vasodilation/physiology , Vasodilator Agents/pharmacology
20.
Biochemistry ; 38(14): 4564-71, 1999 Apr 06.
Article in English | MEDLINE | ID: mdl-10194378

ABSTRACT

Myelopoietins (MPOs) are a family of engineered dual interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptor agonists that are superior in comparison to the single agonists in their ability to promote the growth and maturation of hematopoietic cells of the myeloid lineage. A series of MPO molecules were created which incorporated circularly permuted G-CSF (cpG-CSF) sequences with an IL-3 receptor (IL-3R) agonist moiety attached at locations that correspond to the loops that connect the helices of the G-CSF four-helix bundle structure. The cpG-CSF linkage sites (using the original sequence numbering) were residue 39, which is at the beginning of the first loop connecting helices 1 and 2; residue 97, which is in the turn connecting helices 2 and 3; and residues 126, 133, and 142, which are at the beginning, middle, and end, respectively, of the loop connecting helices 3 and 4. The N- and C-terminal helices of each cpG-CSF domain were constrained, either by direct linkage of the termini (L0) or by replacement of the amino-terminal 10-residue segment with a seven-residue linker composed of SGGSGGS (L1). All of the MPO molecules stimulated the proliferation of both IL-3-dependent (EC50 = 13-95 pM) and G-CSF-dependent (EC50 = 35-710 pM) cell lines. MPOs with the IL-3R agonist domain linked to cpG-CSFs in the first (residue 39) or second (residue 133) long overhand loops were found by CD spectroscopy to have helical contents similar to that expected for a protein comprised of two linked four-helix bundles. The MPOs retained the ability to bind to the IL-3R with affinities similar to that of the parental MPO. Using both a cell surface competitive binding assay and surface plasmon resonance detection of binding kinetics, the MPOs were found to bind to the G-CSF receptor with low nanomolar affinities, similar to that of G-CSF(S17). In a study of isolated cpG-CSF domains [Feng, Y., et al. (1999) Biochemistry 38, 4553-4563], domains with the L1 linker had lower G-CSF receptor-mediated proliferative activities and conformational stabilities than those which had the L0 linker. A similar trend was found for the MPOs in which the G-CSFR agonist activity is mostly a property of the cpG-CSF domain. Important exceptions were found in which the linkage to the IL-3R agonist domain either restored (e.g., attachment at residue 142) or further decreased (linkage at residue 39) the G-CSFR-mediated proliferative activity. MPO in which the IL-3R agonist domain is attached to the cpG-CSF(L1)[133/132] domain was shown to be more potent than the coaddition of the IL-3R agonist and G-CSF in stimulating the production of CFU-GM colonies in a human bone marrow-derived CD34+ colony-forming unit assay. Several MPOs also had decreased proinflammatory activity in a leukotriene C4 release assay using N-formyl-Met-Leu-Phe-primed human monocytes. It was found that circular permutation of the G-CSF domain can alter the ratio of G-CSFR:IL-3R agonist activities, demonstrating that it is a useful tool in engineering chimeric proteins with therapeutic potential.


Subject(s)
Hematopoietic Cell Growth Factors/pharmacology , Peptide Fragments/genetics , Protein Engineering , Receptors, Granulocyte Colony-Stimulating Factor/agonists , Receptors, Granulocyte Colony-Stimulating Factor/genetics , Recombinant Fusion Proteins , Recombinant Fusion Proteins/chemical synthesis , Amino Acid Sequence , Animals , Binding Sites/genetics , Cell Division/drug effects , Cell Line , Circular Dichroism , Granulocyte Colony-Stimulating Factor , Humans , Interleukin-3 , Leukotriene C4/blood , Leukotriene C4/metabolism , Mice , Models, Molecular , Molecular Sequence Data , Peptide Fragments/agonists , Peptide Fragments/metabolism , Protein Engineering/methods , Protein Structure, Tertiary , Receptors, Granulocyte Colony-Stimulating Factor/metabolism , Receptors, Interleukin-3/agonists , Receptors, Interleukin-3/genetics , Receptors, Interleukin-3/metabolism , Recombinant Fusion Proteins/agonists , Recombinant Fusion Proteins/metabolism , Recombinant Proteins , Surface Plasmon Resonance
SELECTION OF CITATIONS
SEARCH DETAIL